<DOC>
	<DOCNO>NCT00502476</DOCNO>
	<brief_summary>To determine daily bath chlorhexidine impregnate washcloth reduce incidence MRSA VRE within Intensive Care Unit ( ICU ) ward setting .</brief_summary>
	<brief_title>Multicenter Trial Daily Chlorhexidine Bathing Reduce Nosocomial Infections</brief_title>
	<detailed_description>This cluster randomize , crossover-controlled trial ward unit randomization . The trial predominantly take place ICU 's may include acute care ward active surveillance MRSA VRE place ( i.e. , Bone Marrow transplant unit , Oncology ward , etc . ) Units randomly assign utilize two bath routine random order . Each bath routine utilized admit patient unit six month study period total study duration 12 month . The two bathing routine include either use Comfort® Bath Washcloth System ( control ) use 2 % Chlorhexidine Gluconate Cloth . Randomized unit either start 2 % Chlorhexidine Gluconate Cloth six month switch Comfort™ Bath Washcloth remain six month period reverse order . Data collection include surveillance clinical culture MRSA VRE bloodstream infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>All patient admit study unit propose study interval eligible inclusion study Patients know allergy chlorhexidine gluconate ingredient product Patients burn include high percentage disrupt body surface area Use patient undergo lumbar puncture contact meninges Patients large open skin wound ; Children le 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>MRSA</keyword>
	<keyword>VRE</keyword>
	<keyword>BSI</keyword>
</DOC>